Amtech Esters IPO: price band, issue size, subscription, GMP trend and listing outcome

Amtech Esters Limited came to the market with an SME (small and medium enterprises) IPO of ₹17.88 crore at a price band of ₹71–₹75 per share. The issue opened on September 9, 2026 and closed on September 11, 2026. It was entirely a fresh issue of ₹17.88 crore with no offer for sale (OFS), meaning the proceeds were proposed to go to the company and not to selling shareholders. The IPO listed on September 17, 2026 at ₹100, which is a 33.33% gain over the upper end of the price band.

What Amtech Esters does: UPR manufacturing plus traded FRP inputs and pigments

Amtech Esters Limited is a business-to-business (B2B) chemical manufacturer focused on Unsaturated Polyester Resins (UPR). In the IPO context, UPR is described as the core revenue driver.

Alongside manufacturing, the company distributes complementary fibre-reinforced plastic (FRP) and resin consumables such as fibre resin, hardeners, ancillary items and silicone-based products. This adds a traded portfolio to the group’s manufacturing base.

A key part of the group structure is its wholly owned subsidiary, Croda Pigments Private Limited, which manufactures pigments used as colourants and additives for resin-based and other industrial and household applications. The integrated resin-and-pigment product basket is supported by in-house research and development (R&D), quality control (QC) and ISO 9001:2015 quality systems.

The company also highlights a diversified stock keeping unit (SKU) portfolio across end-use segments including automotive, electrical and switchgear, FRP, coatings and decorative applications.

Key milestones and footprint: corporate changes and Haryana concentration

Amtech Esters was incorporated in 2002 as Amtech Esters Private Limited. It converted into a public limited company in 2023 as Amtech Esters Limited.

In 2023, the company acquired Croda Pigments Private Limited as a subsidiary, which became a wholly owned subsidiary in 2026.

On operating footprint, the supplied disclosures highlight manufacturing concentration in Haryana. The opportunities narrative also notes an additional UPR unit at Asoda, Haryana, expected to be operational by September 2026.

IPO structure, reservations and what the company said it would use proceeds for

The IPO was a 100% fresh issue with no OFS component. For investors, this structure means dilution is used to raise primary capital, and any deployment of proceeds is proposed spending by the company.

The stated objects of the issue include:

Investment in the wholly owned subsidiary, Croda Pigments Private Limited, by way of debt towards its capital expenditure requirements and incremental working capital requirements.

Repayment or prepayment, in full or in part, of certain borrowings availed by Amtech Esters.

Funding inorganic growth through unidentified acquisitions and general corporate purposes (without a specified allocation amount in the supplied context).

Within the disclosed proposed allocation, ₹8.81 crore is earmarked for the subsidiary (as debt for capital expenditure and incremental working capital) and ₹4.20 crore is earmarked for repayment or prepayment of certain borrowings.

For category reservations, the snapshot reports the issue being allocated across Qualified Institutional Buyers (QIB), Non-Institutional Investors (NII) and Retail Individual Investors (RII), with anchor allocation parameters also disclosed.

Financial trajectory: revenue, profitability and assets across FY2024–FY2026

Across the financial years presented (FY2024–FY2026), Amtech Esters reported growth in total revenue from ₹27.24 crore in FY2024 to ₹40.75 crore in FY2026, while profit after tax (PAT) rose from ₹2.85 crore to ₹4.28 crore. Reported PAT margin remained around the 10% range across the three years, indicating that net profitability as a share of revenue was broadly stable over the disclosed period. Total assets were ₹34.47 crore in FY2024, ₹27.86 crore in FY2025 and ₹34.47 crore in FY2026.

Margin and return indicators disclosed with the IPO include an EBITDA (earnings before interest, taxes, depreciation and amortisation) margin of 18.41% and a PAT margin of 10.28%. The snapshot also reports return on equity (ROE) and return on net worth (RoNW) at 24.17% and return on capital employed (ROCE) at 30.16%.

Working capital is a recurring disclosure theme in the supplied SWOT and risks: receivables are described as large, and debtor days are stated to have risen to 92. For a B2B manufacturing-and-distribution model, collections and credit terms can influence borrowing needs and cash flows.

Valuation and KPI context: reported multiples and capital structure indicators

Based on the IPO snapshot, key valuation and performance indicators include earnings per share (EPS) of ₹6.55 and a pre-IPO price-to-earnings (P/E) multiple of 11.45 times. The price-to-book value is reported at 2.47 times. The debt-to-equity ratio is reported at 0.17 times.

These indicators sit alongside the business mix described in the offer context: UPR manufacturing as the core revenue driver, pigments manufactured through Croda Pigments Private Limited, and distribution of complementary FRP/resin consumables. The mix is relevant because manufacturing and traded product sales can have different working-capital and margin profiles, even though the supplied context does not provide segment-level financial splits.

Subscription, grey market premium trend and listing result

The IPO is marked closed in the snapshot, with total subscription of 2.82 times. Category-wise, the snapshot shows QIB subscription at 1.00 time, NII subscription at 3.47 times and RII subscription at 3.58 times.

The grey market premium (GMP) is an unofficial indicator and can change. In the latest 10 GMP observations provided (referenced to an issue price of ₹75), the GMP ranged from ₹7 to ₹16. The series includes multiple ₹7 observations between September 11 and September 15, 2026, followed by ₹10 and ₹13, and then ₹16 by September 16 and September 17, 2026.

On listing, the snapshot reports a listing price of ₹100, implying a 33.33% listing gain versus the upper end of the price band (₹75).

Key risks and monitoring points based on the supplied disclosures

The supplied risk and SWOT disclosures highlight concentration risks and operating risks that investors typically track for chemical manufacturers and distributors.

One stated business risk is reliance on a single core product category: heavy dependence on UPR means demand or pricing changes in that category could affect earnings and cash generation. Geographic concentration is also highlighted: manufacturing is concentrated in Haryana, raising exposure to local disruption.

Commercial concentration features in the disclosures as well. The top 10 customers are stated to contribute about 40%–45% of revenue across FY2024–FY2026, while the top 10 suppliers are stated to contribute about 66%–73% of purchases across the same period.

The threats disclosure also points to hazardous-chemical and environmental compliance requirements, operational hazards inherent to chemical manufacturing (including fire, explosions and accidents), competition from larger players with greater resources and wider market reach, and feedstock/energy and supply-chain volatility as sector challenges. The weaknesses disclosure notes that insurance does not cover certain risks such as product liability or defect and loss of profits.

Monitoring points that follow from the stated disclosures include:

Working-capital discipline, particularly whether receivables and debtor days remain controlled as operations scale.

Execution of the proposed funding into Croda Pigments Private Limited for capital expenditure and incremental working capital.

Any movement in borrowings after the proposed repayment or prepayment of certain company-level debt.

Whether customer and supplier concentration levels change as the resin-and-pigment platform expands.

Complete numeric snapshot

IPO terms and schedule

Key performance indicators and valuation

Category reservations and anchor allocation

Proposed use of fresh issue proceeds

Subscription status (19 Sep 2026)

Grey market premium (GMP) trend

GMP is an unofficial market indicator and can change; these are dated snapshot observations, not a listing forecast.